$1.99
-0.00800-0.40%
At close: -
$2.05
0.062.91%
After Hours: Jan 28, 5:18 PM EDT
Cocrystal Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cocrystal Pharma using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-0.49 | $-0.57 | 14.0 % |
Q2 | 2024-08-14 | $-0.53 | $-0.48 | -10.4 % |
Q1 | 2024-05-13 | $-0.39 | $-0.54 | 27.8 % |
Q4 | 2024-03-28 | $-0.44 | $-0.60 | 26.7 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q2 | 2023-08-14 | $0 | $270.00K | -100.0 % |
Q1 | 2023-05-15 | $0 | $170.00K | -100.0 % |
Q3 | 2022-11-14 | $0 | $80.00K | -100.0 % |
Cocrystal Pharma (COCP) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-0.49, which beat the estimate of $-0.57.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.